An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Clinical trial NCT02398461 · COMPLETED
Trial details
- NCT number
- NCT02398461
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-09-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.